133 related articles for article (PubMed ID: 18806745)
1. Influence of teichoic acid from S. aureus on metabolic activity of macrophages and cytotoxic activity of splenocytes of mice bearing Lewis lung carcinoma.
Potebnya GP; Skivka LM; Pozur VV; Rudik MP; Senchilo NV; Fedorchuk OG; Khranovska NM
Exp Oncol; 2008 Sep; 30(3):220-3. PubMed ID: 18806745
[TBL] [Abstract][Full Text] [Related]
2. Combined influence of teichoic acids from Staphylococcus aureus and heterometallik Cu/Cd ethylenediamine complex on peritoneal macrophages and tumor cells.
Nikulina VV; Garmanchuk LV; Senchylo NV; Nikolaenko TV; Dzhus OI; Ostapchenko LI; Khranovska NM
Tsitol Genet; 2014; 48(6):56-61. PubMed ID: 25536823
[TBL] [Abstract][Full Text] [Related]
3. Experimental study of the efficacy of combined use of cancer vaccine and interferon.
Potebnya GP; Kudryavets YY; Lisovenko GS; Cheremshenko NL; Voeykova IM; Trokhimenko NV; Symchich TV; Evstrateyva LM
Exp Oncol; 2007 Jun; 29(2):102-5. PubMed ID: 17704740
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of spleen cell cytotoxic capacity toward tumor by elevated prostaglandin E2 levels in mice bearing Lewis lung carcinoma.
Young MR; Hoover CS
J Natl Cancer Inst; 1986 Aug; 77(2):425-9. PubMed ID: 2942724
[TBL] [Abstract][Full Text] [Related]
5. Augmenting major histocompatibility complex class I expression by murine tumors in vivo enhances antitumor immunity induced by an active immunotherapy strategy.
Merritt RE; Yamada RE; Crystal RG; Korst RJ
J Thorac Cardiovasc Surg; 2004 Feb; 127(2):355-64. PubMed ID: 14762342
[TBL] [Abstract][Full Text] [Related]
6. Total flavonoids of Daphne genkwa root significantly inhibit the growth and metastasis of Lewis lung carcinoma in C57BL6 mice.
Zheng W; Gao X; Chen C; Tan R
Int Immunopharmacol; 2007 Feb; 7(2):117-27. PubMed ID: 17178377
[TBL] [Abstract][Full Text] [Related]
7. 5-aminolevulinic acid mediated photodynamic therapy of Lewis lung carcinoma: a role of tumor infiltration with different cells of immune system.
Skivka LM; Gorobets OB; Kutsenok VV; Lozinsky MO; Borisevich AN; Fedorchuk AG; Kholin VV; Gamaleya NF
Exp Oncol; 2004 Dec; 26(4):312-5. PubMed ID: 15627065
[TBL] [Abstract][Full Text] [Related]
8. Antitumor and antimetastatic activities of vaccine prepared from cisplatin-resistant lewis lung carcinoma.
Potebnya GP; Voeykova IM; Lisovenko GS; Cheremshenko NL; Todor IM; Yudina OY; Kovtonyuk OV; Chekhun VF
Exp Oncol; 2009 Dec; 31(4):226-30. PubMed ID: 20010530
[TBL] [Abstract][Full Text] [Related]
9. Peritoneal and splenic macrophage functions in the tumor-bearing host.
Gardner TE; Naama H; Daly JM
J Surg Res; 1995 Aug; 59(2):305-10. PubMed ID: 7637346
[TBL] [Abstract][Full Text] [Related]
10. Changes in VEGF level and tumor growth characteristics during lewis lung carcinoma progression towards cis-DDP resistance.
Pyaskovskaya ON; Dasyukevich OI; Kolesnik DL; Garmanchouk LV; Todor IN; Solyanik GI
Exp Oncol; 2007 Sep; 29(3):197-202. PubMed ID: 18004244
[TBL] [Abstract][Full Text] [Related]
11. Effect of Ukrain on the growth and metastasizing of Lewis carcinoma in C57BL/6 mice.
Grinevich Y; Shalimov S; Bendyuh G; Zahriychuk O; Hodysh Y
Drugs Exp Clin Res; 2005; 31(2):59-70. PubMed ID: 15929607
[TBL] [Abstract][Full Text] [Related]
12. Modulation of immune effector cell cytolytic activity and tumour growth inhibition in vivo by Ukrain (NSC 631570).
Liepins A; Nowicky JW
Drugs Exp Clin Res; 1996; 22(3-5):103-13. PubMed ID: 8899312
[TBL] [Abstract][Full Text] [Related]
13. Response of different organs of immune system of mice upon administration bacterial CpG DNA.
Olishevsky S; Shlyakhovenko V; Kozak V; Yanish Y
Exp Oncol; 2005 Dec; 27(4):290-7. PubMed ID: 16404349
[TBL] [Abstract][Full Text] [Related]
14. Opposite effects on tumor growth depending on dose of Achyranthes bidentata polysaccharides in C57BL/6 mice.
Jin LQ; Zheng ZJ; Peng Y; Li WX; Chen XM; Lu JX
Int Immunopharmacol; 2007 May; 7(5):568-77. PubMed ID: 17386404
[TBL] [Abstract][Full Text] [Related]
15. Immunotherapy with dendritic cells pulsed with tumor-derived gp96 against murine lung cancer is effective through immune response of CD8+ cytotoxic T lymphocytes and natural killer cells.
Shinagawa N; Yamazaki K; Tamura Y; Imai A; Kikuchi E; Yokouchi H; Hommura F; Oizumi S; Nishimura M
Cancer Immunol Immunother; 2008 Feb; 57(2):165-74. PubMed ID: 17628800
[TBL] [Abstract][Full Text] [Related]
16. Anti-tumor metastatic activity of beta-glucan purified from mutated Saccharomyces cerevisiae.
Yoon TJ; Kim TJ; Lee H; Shin KS; Yun YP; Moon WK; Kim DW; Lee KH
Int Immunopharmacol; 2008 Jan; 8(1):36-42. PubMed ID: 18068098
[TBL] [Abstract][Full Text] [Related]
17. [Treatment of spontaneous metastatic lung cancer with tumor antigen-pulsed, interleukin-18 gene-modified dendritic cells].
Chen J; Cao X; Xiu Q
Zhonghua Yi Xue Za Zhi; 2001 Jul; 81(13):779-82. PubMed ID: 11798964
[TBL] [Abstract][Full Text] [Related]
18. Changes in natural killer cells activity in mice bearing subcutaneously implanted Lewis lung carcinoma.
Budzyński W
Arch Immunol Ther Exp (Warsz); 1984; 32(2):185-9. PubMed ID: 6487051
[TBL] [Abstract][Full Text] [Related]
19. T-cell subset analysis of Lewis lung carcinoma tumor rejection: heterogeneity of effectors and evidence for negative regulatory lymphocytes correlating with metastasis.
Gelber C; Eisenbach L; Feldman M; Goodenow RS
Cancer Res; 1992 Dec; 52(23):6507-15. PubMed ID: 1423297
[TBL] [Abstract][Full Text] [Related]
20. Induction of highly immunogenic variants of Lewis lung carcinoma tumor by ultraviolet irradiation.
Peppoloni S; Herberman RB; Gorelik E
Cancer Res; 1985 Jun; 45(6):2560-6. PubMed ID: 2580624
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
